Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-25-067048
Filing Date
2025-07-23
Accepted
2025-07-23 17:27:35
Documents
7
Effectiveness Date
2025-07-23

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0250018-s8_psyence.htm S-8 48231
2 OPINION OF WEIRFOULDS LLP ea025001801ex5-1_psyence.htm EX-5.1 22238
3 CONSENT OF MNP LLP ea025001801ex23-1_psyence.htm EX-23.1 4634
4 FILING FEE TABLE ea025001801ex-fee_psyence.htm EX-FILING FEES 11514
5 GRAPHIC ex5-1_001.jpg GRAPHIC 10171
6 GRAPHIC ex23-1_001.jpg GRAPHIC 26263
7 GRAPHIC ex23-1_002.jpg GRAPHIC 7512
  Complete submission text file 0001213900-25-067048.txt   148652
Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1 27744604171
PSYENCE BIOMEDICAL LTD. (Filer) CIK: 0001985062 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-288905 | Film No.: 251143911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)